Chemical name: 1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine
Formula: C23H32N6O4S
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

FILITRA PROFESSIONAL (SUBLINGUAL)

Introduction

FILITRA PROFESSIONAL (SUBLINGUAL) is a medication manufactured by Fortune Health Care, containing vardenafil as its active substance. It belongs to the class of medications known as phosphodiesterase type 5 (PDE5) inhibitors and is primarily used in the treatment of erectile dysfunction (ED) in adult men. This description provides an overview of FILITRA PROFESSIONAL (SUBLINGUAL), its characteristics, clinical applications, and considerations.

Characteristics

1. Active Substance: FILITRA PROFESSIONAL (SUBLINGUAL) contains vardenafil, a potent PDE5 inhibitor that works by increasing blood flow to the penis during sexual stimulation. Vardenafil helps relax the smooth muscles of the blood vessels in the penis, allowing for improved erectile function and the ability to achieve and maintain a satisfactory erection.
2. Formulation: FILITRA PROFESSIONAL (SUBLINGUAL) is available in the form of sublingual tablets, with each tablet containing a specific dosage of vardenafil. The tablets are designed to be placed under the tongue and dissolved rapidly, allowing for faster onset of action compared to conventional oral tablets.

Clinical Applications

1. Erectile Dysfunction: FILITRA PROFESSIONAL (SUBLINGUAL) is indicated for the treatment of erectile dysfunction, a common condition characterized by the inability to achieve or sustain an erection sufficient for satisfactory sexual performance. Vardenafil helps improve erectile function by enhancing blood flow to the penis, resulting in firmer and longer-lasting erections.

Considerations

1. Dosage and Administration: The recommended dosage of FILITRA PROFESSIONAL (SUBLINGUAL) may vary depending on individual patient factors such as the severity of erectile dysfunction and response to treatment. It is typically administered as needed, approximately 25 to 60 minutes before sexual activity. The sublingual tablet should be placed under the tongue and allowed to dissolve completely without chewing or swallowing.
2. Effectiveness: FILITRA PROFESSIONAL (SUBLINGUAL) has been shown to be effective in improving erectile function and increasing the likelihood of successful intercourse in men with erectile dysfunction. However, sexual stimulation is still required for vardenafil to exert its effects, as it does not cause spontaneous erections.
3. Adverse Effects: Common adverse effects associated with FILITRA PROFESSIONAL (SUBLINGUAL) may include headache, flushing, nasal congestion, dyspepsia (indigestion), and dizziness. These side effects are usually mild to moderate in severity and transient in nature. Patients should report any persistent or bothersome symptoms to their healthcare provider.
4. Drug Interactions: Vardenafil may interact with certain medications, particularly nitrates used to treat chest pain (angina) and alpha-blockers used to treat high blood pressure. Concomitant use of vardenafil with these medications may cause a sudden drop in blood pressure, leading to dizziness, fainting, or other cardiovascular complications.
5. Contraindications: FILITRA PROFESSIONAL (SUBLINGUAL) is contraindicated in individuals with a known hypersensitivity to vardenafil or any of its components, as well as in patients who are taking nitrates or nitric oxide donors for chest pain or heart conditions. It should not be used in combination with other PDE5 inhibitors or alpha-blockers unless under the guidance of a healthcare provider.

Conclusion

FILITRA PROFESSIONAL (SUBLINGUAL), containing vardenafil as its active substance, is a valuable medication for the treatment of erectile dysfunction in adult men. With its rapid onset of action and effective results, FILITRA PROFESSIONAL (SUBLINGUAL) offers a convenient and reliable option for improving erectile function and enhancing sexual satisfaction. However, its use should be guided by a qualified healthcare provider to ensure safe and appropriate treatment outcomes, and patients should be educated about potential side effects and drug interactions.